Capricor gets Form 483 from FDA; WuXi Biologics' new China factory 

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Capricor Therapeutics has received a Form 483 from the FDA after an inspection of its factory ...

Related Posts

Future Covid vaccine approvals may narrow to older adul...

May 20, 2025  0

Updated: MD Anderson-allied investment firm targets $25...

May 28, 2025  0

Trump health appointees pledge support for cell and gen...

Jun 5, 2025  0

Comments

Name

Email

Comment

Post Comment